21 October 2019, Gothenburg/Sweden
Thomas Schoenknecht has over 20 years’ experience in the pharmaceutical industry in various leading roles such as project management, research & development and business development. Before joining LONZA in 2019 as Head of Research and Development of DrugProductServices, Thomas has been with SHL since 2013 as an Executive
Director of Business Development, responsible for global Business Development, Key Account Management and new Technology Evaluation, Thomas has gained experience in various leading positions in product and business development at Schott Pharmaceutical Packing Division, Amgen Inc California and Gerresheimer’s Pharmaceutical Packing Division.
Thomas has a Ph.D. in Biophysical Chemistry from the Max-Planck-Society and the University Goettingen, Germany and a Master’s degree in Chemistry from the University Goettingen.
Michael is Senior Manager of Global Development QA External Collaboration at Sandoz.He has a background in Microbiology and Business Administration with over 10 years of experience in the pharmaceutical industry. Michael has held key quality roles in operations and development, including roles as a GxP Auditor, QA Compliance Manager and Global Quality Project Manager.
Michael has gathered regulatory knowledge having worked with regulatory authorities for years on a European and International level in the area of medicinal products, medical devices and food supplements (cGxP, CFR 21 Part 4, CFR 820, MDD, MDR, SaMD).>/p>